Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Osteoarthritis Cartilage ; 11(11): 821-30, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14609535

RESUMEN

OBJECTIVE: To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA). METHODS: Intra-articular injections of MIA and saline were administered to male Wistar rats (175-200 g) into the right and left knee joints, respectively. Changes in hind paw weight distribution between the right (osteoarthritic) and left (contralateral control) limbs were utilized as an index of joint discomfort. Acetaminophen and two archetypal, orally administered NSAIDs, naproxen and rofecoxib, were examined for their ability to decrease MIA-induced change in weight distribution. RESULTS: A concentration-dependent increase in change in hind paw weight distribution was noted after intra-articular injection of MIA. Both naproxen and rofecoxib demonstrated the capacity to significantly (P<0.05) decrease hind paw weight distribution in a dose-dependent fashion, indicating that the change in weight distribution associated with MIA injection is susceptible to pharmacological intervention. CONCLUSION: The determination of differences in hind paw weight distribution in the rat MIA model of OA is a technically straightforward, reproducible method that is predictive of the effects of anti-inflammatory and analgesic agents. This system may be useful for the discovery of novel pharmacologic agents in human OA.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Artritis Experimental/fisiopatología , Osteoartritis/fisiopatología , Soporte de Peso , Acetaminofén/uso terapéutico , Analgésicos no Narcóticos/uso terapéutico , Animales , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/patología , Progresión de la Enfermedad , Relación Dosis-Respuesta a Droga , Miembro Posterior/fisiopatología , Yodoacetatos , Masculino , Osteoartritis/inducido químicamente , Osteoartritis/tratamiento farmacológico , Osteoartritis/patología , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
2.
EMBO J ; 18(20): 5476-85, 1999 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-10523292

RESUMEN

The regulation of peroxisomal motility was investigated both in CHO cells and in cells derived from human umbilical vein endothelium (HUE). The cells were transfected with a construct encoding the green fluorescent protein bearing the C-terminal peroxisomal targeting signal 1. Kinetic analysis following time-lapse imaging revealed that CHO cells respond to simultaneous stimulation with ATP and lysophosphatidic acid (LPA) by reducing peroxisomal movements. When Ca(2+) was omitted from the extracellular medium or the cells were incubated with inhibitors for heterotrimeric G(i)/G(o) proteins, phospholipase C, classical protein kinase C isoforms (cPKC), mitogen-activated protein kinase kinase (MEK) or phospholipase A(2) (PLA(2)), this signal-mediated motility block was abolished. HUE cells grown to confluency on microporous membranes responded similarly to ATP-LPA receptor co-stimulation, but only when the ligands had access to the basolateral membrane region. These data demonstrate that peroxisomal motility is subject to specific modulation from the extracellular environment and suggest a receptor-mediated signaling cascade comprising Ca(2+) influx, G(i)/G(o) proteins, phospholipase C, cPKC isoforms, MEK and PLA(2) being involved in the regulation of peroxisomal arrest.


Asunto(s)
Peroxisomas/fisiología , Receptores de Superficie Celular/fisiología , Receptores Acoplados a Proteínas G , Receptores Purinérgicos P2/fisiología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/farmacología , Animales , Células CHO , Polaridad Celular , Células Cultivadas , Cricetinae , Citosol/fisiología , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Activación Enzimática/efectos de los fármacos , Humanos , Lisofosfolípidos/farmacología , Movimiento/efectos de los fármacos , Movimiento/fisiología , Peroxisomas/efectos de los fármacos , Fosfolipasas A/metabolismo , Receptores de Superficie Celular/efectos de los fármacos , Receptores del Ácido Lisofosfatídico , Receptores Purinérgicos P2/efectos de los fármacos , Transducción de Señal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...